ClosedBusiness2020 Early Stage Translation and Commercialisation Support Grant Opportunity

MRFF 2020 Early Stage Translation and Commercialisation Support Grant Opportunity

Australian Government · Australia

This grant provides funding to eligible organisations to work in partnership with Australian small to medium-sized enterprises to translate medical innovation and research into early stage commercialisation activities. It supports projects across preclinical research, novel drugs, medical devices and digital health technologies.

Official Grant Page

Location

Australia

Who Can Apply

Must have an active Australian Business Number and be incorporated in Australia. Must be an eligible entity such as a medical research institute, university, corporate Commonwealth entity, or corporation. Must partner with Australian small to medium-sized enterprises and provide required board or CEO support evidence and partner letters where applicable. Individuals, partnerships, unincorporated associations, trusts without an incorporated trustee, and non-corporate Commonwealth entities are not eligible.
To be eligible, applicants must have an Australian Business Number, be incorporated in Australia, and in accordance with section 24 of the MRFF Act 2015 be one of the following entities: a medical research institute, a university, a corporate Commonwealth entity, or a corporation including businesses and not for profits. Joint applications are encouraged where there is an eligible lead organisation. Applicants must provide evidence from their board or chief executive officer or equivalent that the project is supported and that they can complete the project and meet project costs not covered by grant funding, and letters of support from each project partner where applicable. All project team members must be listed on the application form as Project Managers, and a Project Manager A must be nominated. Individuals, partnerships, unincorporated associations, organisations not included in section 3.1 of the guidelines, trusts except where an incorporated trustee applies on behalf of a trust, and non-corporate Commonwealth entities are not eligible.

What's Funded

Funded activities include partnering with Australian small to medium-sized enterprises to progress early stage medical research and medical innovation projects through preclinical development, early clinical development of novel drugs or new uses for existing drugs, development of medical devices, and early stage digital health technology development.

Expected Outcomes

Projects are expected to progress Australian medical research and innovation through early development so they become de-risked and more attractive to private investment for commercialisation, improving the health and wellbeing of Australians.

Key Information

Applicant Types

companynon_profituniversityother

Stage

any

Funding Purposes

researchinnovationcommercialisationr_and_d

Keywords

medical researchmedical innovationcommercialisationMRFFhealthdigital healthmedical devicesnovel drugs

Frequently Asked Questions

What is the MRFF 2020 Early Stage Translation and Commercialisation Support Grant Opportunity?

The MRFF 2020 Early Stage Translation and Commercialisation Support Grant Opportunity is a business grant offered by Australian Government in Australia. This grant provides funding to eligible organisations to work in partnership with Australian small to medium-sized enterprises to translate medical innovation and research into early stage commercialisation activities. It supports projects across preclinical research, novel drugs, medical devices and digital health technologies.

Who is eligible for the MRFF 2020 Early Stage Translation and Commercialisation Support Grant Opportunity?

Must have an active Australian Business Number and be incorporated in Australia. Must be an eligible entity such as a medical research institute, university, corporate Commonwealth entity, or corporation. Must partner with Australian small to medium-sized enterprises and provide required board or CEO support evidence and partner letters where applicable. Individuals, partnerships, unincorporated associations, trusts without an incorporated trustee, and non-corporate Commonwealth entities are not eligible.

What activities are funded?

Funded activities include partnering with Australian small to medium-sized enterprises to progress early stage medical research and medical innovation projects through preclinical development, early clinical development of novel drugs or new uses for existing drugs, development of medical devices, and early stage digital health technology development.

How do I apply for the MRFF 2020 Early Stage Translation and Commercialisation Support Grant Opportunity?

Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.

Need help applying?

Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.

Start with Beta DocsBook a free consultation